EUVIMEDEUVIMED entdecken
Crossref

Eosinophil‐To‐Lymphocyte Ratio and Neutrophil‐To‐Lymphocyte Ratio in Erythroderma: An Exploratory Subtype‐Stratified Pilot Study

Yanchen Liu iD, Linfeng Li iD

The Journal of Dermatology · 2026-11 · 53 (11) · 1671-1681

DOI: 10.1111/1346-8138.70475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, online erschienen am 30.08.2026. Verfasst von Yanchen Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Dermatitis, Exfoliative, Eosinophils, Neutrophils, Psoriasis. Die Arbeit nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erythroderma is most often secondary to psoriasis, atopic dermatitis (AD), or drug eruption. These three subtypes have different immune mechanisms, but most biomarker studies treat erythroderma as one condition. We examined whether routine complete blood count (CBC) indices behave differently across the three subtypes. This was a single‐center retrospective study of inpatients admitted between April 2015 and March 2026. We compared eosinophil‐to‐lymphocyte ratio (ELR), absolute eosinophil count (AEC), and neutrophil‐to‐lymphocyte ratio (NLR) between erythroderma cases and non‐erythrodermic controls within each subtype, with Benjamini–Hochberg correction. We assessed ROC discrimination using a 5 000‐iteration bootstrap and Harrell's optimism correction. Of 375 inpatients (18, 19, and 19 erythroderma cases in psoriasis‐type, AD‐type, and drug eruption‐type), ELR was higher in cases than controls in all three subtypes (all q ≤ 0.007), with corrected AUCs of 0.84, 0.69, and 0.80. NLR was higher in cases for psoriasis‐type (AUC 0.71) and AD‐type (AUC 0.75) but not for drug eruption‐type (AUC 0.56). In AD‐type, a combined model with ELR and NLR gave a corrected AUC of 0.76; no gain was seen in the other two subtypes. In this small exploratory cohort, ELR appears higher in erythroderma across the three subtypes, while NLR carries information only in psoriasis‐type and AD‐type. The pattern is consistent with eosinophil‐compartment activity being a shared feature and neutrophil‐compartment activity being subtype‐restricted. The findings are hypothesis‐generating and need confirmation in prospective multicenter cohorts that can also control for pre‐admission medication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, ExfoliativeEosinophilsNeutrophilsPsoriasisLymphocytesDermatitis, AtopicDrug EruptionsHumansFemalePilot ProjectsMaleRetrospective StudiesMiddle AgedLeukocyte CountAdultAgedBiomarkersCase-Control Studies

Stichwörter der Autor:innen

atopic dermatitiscomplete blood countdrug eruptioneosinophil‐to‐lymphocyte ratioerythrodermaneutrophil‐to‐lymphocyte ratiopsoriasis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Yanchen Liu, Linfeng Li

Zitieren

APA

Liu, Y., & Li, L. (2026). Eosinophil‐To‐Lymphocyte Ratio and Neutrophil‐To‐Lymphocyte Ratio in Erythroderma: An Exploratory Subtype‐Stratified Pilot Study. The Journal of Dermatology, 53(11), 1671-1681. https://doi.org/10.1111/1346-8138.70475

Vancouver

Liu Y, Li L. Eosinophil‐To‐Lymphocyte Ratio and Neutrophil‐To‐Lymphocyte Ratio in Erythroderma: An Exploratory Subtype‐Stratified Pilot Study. The Journal of Dermatology. 2026;53(11):1671-1681. doi:10.1111/1346-8138.70475

BibTeX
@article{Liu2026,
  author = {Liu, Yanchen and Li, Linfeng},
  title = {Eosinophil‐To‐Lymphocyte Ratio and Neutrophil‐To‐Lymphocyte Ratio in Erythroderma: An Exploratory Subtype‐Stratified Pilot Study},
  journal = {The Journal of Dermatology},
  year = {2026},
  volume = {53},
  number = {11},
  pages = {1671--1681},
  doi = {10.1111/1346-8138.70475}
}
Kostenlos starten →